THOMSON PHARMA EXCEEDS EXPECTATIONS WITH MORE THAN 100 CUSTOMERS TO DATE
Davos Chemical Corporation One of the First on Board Uses the Solution to Stay Current on Latest Industry Developments
Philadelphia, PA USA-London UK - September 15, 2005 — Launched in January 2005, Thomson PharmaSM is the innovative dynamic information solution for the pharmaceutical and biotechnology industries. Thomson Pharma brings an indispensable information solution to the workflow of the drug discovery and development process, providing research tools that fulfill the information needs of professionals working at all stages of the drug development pipeline. Today, Thomson Scientific, a business of The Thomson Corporation, announced that more than 100 organizations have turned to Thomson Pharma to revolutionize how they manage their flow of information.
One of the first companies to purchase access to Thomson Pharma was Davos Chemical Corporation. Headquartered in Upper Saddle River, New Jersey, Davos is a supplier of custom made API’s and cGMP intermediates for the pharmaceutical industry.
“Our customers are emerging and multinational pharmaceutical companies, whose requirements range from producing gram quantities of Active Pharmaceutical Ingredients (API) for preclinical studies to supplying tons for post launch,” stated Brian Robins, vice president of Davos Chemical Corporation. “Thomson Pharma is a best in class database, providing access to the most complete data available in an efficient search engine. Thomson Pharma enables us to keep up-to-date with the latest developments in our customer’s pipelines as well as to find potential new customers. We regularly mine the database to find, patents, competitive intelligence and new opportunities,” concluded Robins.
Conceived and designed based on customer feedback, Thomson Pharma provides researchers and other professionals in the fields of biology, chemistry, licensing, business development and competitive intelligence with the cutting-edge tools needed to make better decisions faster—whether at a start-up biotech business or a large pharmaceutical corporation.
“In response to our customers, we accepted the challenge to create a resource that would breakdown the information barriers to the business-critical content necessary to maintain a competitive advantage,” said Ian Tarr, executive vice president, Pharmaceutical & Chemical Markets, Thomson Scientific. “We are very encouraged at how quickly our customers have embraced Thomson Pharma, and how they’ve come to view it as a critical information resource throughout the drug discovery process,” added Tarr.
About Thomson Pharma
Thomson Pharma integrates trusted information from Thomson Scientific,
with critical content from other information businesses across Thomson including
content from its Financial, Healthcare and Legal and Regulatory groups. This
integration will provide scientific researchers and other professionals with
the most complete pharmaceutical information source available on the market
today. The core Thomson Pharma content areas include drug information,
intellectual property data, literature and news, company data, chemical information,
sequence data and drug target information, enhanced with value-added content
resources and powerful search tools. Thomson Pharma provides content derived
from well-known legacy products such as Investigational Drugs Database
(IDdb), Derwent World Patents Index®, Delphion®, Web
of Science®, Drugdex®, and many more.
Thomson Reuters (www.thomsonreuters.com), with 2005 revenues of approximately $8.5 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 40,500 employees and provides services in approximately 130 countries. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Scientific is a business of Thomson Reuters. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson scientific information solutions can be found at www.scientific.thomson.com.